当前位置：
X-MOL 学术
›
Am. J. Cardiovasc. Drugs
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Correction to: Dapaglifozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
American Journal of Cardiovascular Drugs ( IF 2.8 ) Pub Date : 2021-12-02 , DOI: 10.1007/s40256-021-00512-7 Hannah A Blair 1
中文翻译：
更正为：达格列净：射血分数降低的症状性心力衰竭综述
更新日期：2021-12-03
American Journal of Cardiovascular Drugs ( IF 2.8 ) Pub Date : 2021-12-02 , DOI: 10.1007/s40256-021-00512-7 Hannah A Blair 1
Affiliation
The article titled “Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction”.
中文翻译：
更正为：达格列净：射血分数降低的症状性心力衰竭综述
文章标题为“Dapagliflozin：射血分数降低的症状性心力衰竭综述”。
京公网安备 11010802027423号